I-MAB (IMAB)
1.76
-0.01
(-0.56%)
USD |
NASDAQ |
May 17, 16:00
1.76
0.00 (0.00%)
After-Hours: 20:00
I-MAB Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 232.66M |
| September 30, 2020 | |
| December 31, 2019 |
| Date | Value |
|---|---|
| September 30, 2019 | 2.138M |
| December 31, 2018 | 1.502M |
| September 30, 2018 | 3.235M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.138M
Minimum
Sep 2019
232.66M
Maximum
Dec 2020
117.40M
Average
117.40M
Median
Revenue (Quarterly) Benchmarks
| Summit Therapeutics Inc | -- |
| Verastem Inc | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.065M |
| IGC Pharma Inc | 0.204M |
Revenue (Quarterly) Related Metrics
| Enterprise Value | -168.22M |
| Earnings Yield | -141.9% |
| Normalized Earnings Yield | -141.86 |